Sun Pharma, Dr Reddy's Labs recall products in US over manufacturing issues Ruchika Sharma5 Dec 2022 1:30 PM ISTThe health regulator further said the US-based arm of Sun Pharma is recalling 14,064 cartons of a medication to treat erosive esophagitis or heartburn...
NPPA fixes retail price of 40 Formulation, Details Dr. Divya Colin25 Nov 2022 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Sun Pharma gets USFDA nod for neonatal seizures treatment SEZABY Ruchika Sharma18 Nov 2022 12:15 PM ISTSEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection.
50 Drug Samples Fail To Qualify CDSCO Test Susmita Roy17 Nov 2022 5:24 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 50 medicine...
Indian Pharma Market registers 7.2 percent growth in October: AIOCD-AWACS Report Farhat Nasim11 Nov 2022 6:00 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has registered a decline in growth for the month of October as industry sales rose only 7.2 percent...
Sun Pharma, SPARC collaborate for commercialization of phenobarbital for injection in US Ruchika Sharma10 Nov 2022 11:23 AM ISTSPARC's phenobarbital sodium powder for injection is a benzyl alcohol and propylene glycol-free formulation intended for the treatment of seizures in...
Sun Pharma Mohali facility gets USFDA OAI status Ruchika Sharma9 Nov 2022 12:30 PM ISTMaharashtra: Pharma major Sun Pharmaceutical Industries Limited has recently announced that the Company has received a communication from the US...
Sun Pharma reports 10.5 percent rise in Q2 profit Ruchika Sharma2 Nov 2022 2:30 PM ISTBengaluru: Sun Pharmaceutical Industries Ltd, India's largest drugmaker, on Tuesday reported a surprise 10.5 percent rise in second-quarter profit led...
US Supreme Court turns down Novartis bid to block launch of multiple sclerosis drug Gilenya generics Ruchika Sharma15 Oct 2022 1:30 PM ISTNovartis settled with some of the drugmakers it had sued, allowing for some Gilenya generics before a key patent's 2027 expiration.
Sun Pharma Gets CDSCO Panel Nod To Study Elagolix tablet Dr. Divya Colin14 Oct 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO panel to Sun Pharma to manufacture Progesterone SR Tablet Roshni Dhar12 Oct 2022 6:30 PM ISTThe drug major Sun Pharma has got green signal from the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization...
Health Bulletin 12/October/2022 Roshni Dhar12 Oct 2022 5:25 PM ISTHere are the top health news for the day:NMC renews permission for 100 MBBS seats at MGM medical college IndoreIndore based Mahatma Gandhi Memorial...
